Application Nr Approved Date Route Status External Links
ANDA075298 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Flutamide Capsules Are Indicated For Use In Combination With Lhrh-Agonists For The Management Of Locally Confined Stage B 2 -C And Stage D 2 Metastatic Carcinoma Of The Prostate. Stage B 2 -C Prostatic Carcinoma Treatment With Flutamide Capsules And The Goserelin Acetate Implant Should Start Eight Weeks Prior To Initiating Radiation Therapy And Continue During Radiation Therapy. Stage D 2 Metastatic Carcinoma To Achieve Benefit From Treatment, Flutamide Capsules Should Be Initiated With The Lhrh-Agonist And Continued Until Progression.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Flutamide FLUTAMIDE ZINC3812944

Comments